Literature DB >> 16570766

Prevention of type 2 diabetes in the prediabetic population.

D Maji1, R U Roy, Sutapa Das.   

Abstract

Prevention of diabetes has been tried by several groups with varying degree of success. Prediabetic population are the ideal target for the purpose. In this study, prediabetic subjects are selected from the high-risk groups, like those having obesity, family history of diabetes, past history of gestational diabetes, hypertension, dyslipidaemia; and are included in the study when their fasting plasma glucose was found to be below 110 mg/dl and 2 hours postglucose (75g) plasma glucose remained between 110 and 200 mg/dl. After giving advice for lifestyle changes to all for a period of 3 months, those who had their blood glucose values in the impaird glucose tolerance (IGT) range were given either metformin, rosiglitazone or acarbose, the rest continued with diet and exercise only. Total follow-up period was 3 years. All groups maintained blood sugar in the euglycaemic range till the end of the 3-year period.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16570766

Source DB:  PubMed          Journal:  J Indian Med Assoc        ISSN: 0019-5847


  3 in total

Review 1.  Treating prediabetes with metformin: systematic review and meta-analysis.

Authors:  Muriel Lily; Muriel Lilly; Marshall Godwin
Journal:  Can Fam Physician       Date:  2009-04       Impact factor: 3.275

2.  Association of central adiposity with prediabetes and decreased insulin sensitivity in rural Chinese normal-weight and overweight women.

Authors:  Yunxian Yu; Scott A Venners; Binyan Wang; Wendy J Brickman; Donald Zimmerman; Zhiping Li; Liuliu Wang; Xue Liu; Genfu Tang; Houxun Xing; Xiping Xu; Xiaobin Wang
Journal:  Metabolism       Date:  2010-01-04       Impact factor: 8.694

3.  Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.

Authors:  Kasper S Madsen; Yuan Chi; Maria-Inti Metzendorf; Bernd Richter; Bianca Hemmingsen
Journal:  Cochrane Database Syst Rev       Date:  2019-12-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.